Wockhardt, Khorakiwalas Pay Rs76.68 Lakh To Settle Non-disclosure of US FDA Inspection
Moneylife Digital Team 23 May 2023
Pharmaceutical company Workhardt Ltd and its founder-chairman Habil Khorakiwala, managing director (MD) Murtaza Khorakiwala and executive director (ED) Huzaifa Khorakiwala agreed to pay Rs76.68 lakh to settle a case with market regulator Securities and Exchange Board of India (SEBI). The case is related to the alleged non-disclosure of adverse observations made by the US food and drug administration (FDA) about the company's manufacturing facility at Waluj near Aurangabad in 2013.
According to the SEBI settlement order, Wockhardt would pay Rs36.70 lakh, while the founder-chairman, MD and ED would pay Rs13.32 lakh each. 
In March 2013, a team from US FDA inspected Wockhardt's Waluj factory and issued form 483, regarded as an adverse observation of factory facilities. However, the company immediately did not disclose information about form 483 issued by US FDA to the stock exchanges. On 15 April 2013, the company announced the issuance of form 483 on its website through a press release.
SEBI then initiated adjudicating proceeding against the company and its top executives. Wockhardt and the Khorakiwalas filed an application for settlement in this case. 
Their authorised representative met SEBI's internal committee to discuss the terms of settlement. The internal committee recommended Rs36.70 lakh for Wockhardt and Rs13.32 lakh each for the top three executives as a full and final settlement of the alleged default. On 22 February 2023, the high-powered committee (HPC) of SEBI considered and approved the settlement. On 3 April 2023, the panel of whole- time members (WTMs) accepted the settlement proposal.
On 4th May, Wockhardt and the Khorakiwalas informed SEBI about remintannce of the settlement amount. 
Adani Stock Saga: Clean Chit by SC Committee Raises Questions & Creates a Worrying New Template for Investigation
Sucheta Dalal, 23 May 2023
A Supreme Court (SC)-appointed expert committee could well become a preferred choice for corporate India, when faced with a major financial scandal requiring a ‘systemically important investigation’. On 6th May, an expert committee...
SEBI Proposes Integration of SCORES with ODR for Improving Investor Grievance Handling
Moneylife Digital Team 22 May 2023
Market regulator Securities and Exchange Board of India (SEBI) floated a consultation paper seeking comments on the proposal to strengthen the investor grievance handling mechanism through SEBI Complaints Redressal System (SCORES)...
Indore-based Investment Research Advisors' Registration Cancelled by SEBI
Moneylife Digital Team 22 May 2023
Market regulator Securities and Exchange Board of India (SEBI) has cancelled the registration license of Indore-based Investment Research Advisors (IRA) and its proprietor Amit Gangrade. Last month, SEBI banned Amit Gangrade and his...
Meta fined record $1.3 bn for violating EU data transfer rules
IANS 22 May 2023
The Irish Data Protection Commission on Monday fined Meta (formerly Facebook) a record $1.3 billion fine over violating data transfer rules in the European Union (EU).
The Irish watchdog said that Meta violated the General...
Free Helpline
Legal Credit